Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis

por Harry, Rachel A, Anderson, Amy E, Isaacs, John D, Hilkens, Catharien M U
Publicado 2010

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies

por Cooles, Faye A. H., Anderson, Amy E., Drayton, Tracey, Harry, Rachel A., Diboll, Julie, Munro, Lee, Thalayasingham, Nishanthi, Östör, Andrew J. K., Isaacs, John D.
Publicado 2016

LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells

por Anderson, Amy E., Swan, David J., Sayers, Bethan L., Harry, Rachel A., Patterson, Angela M., von Delwig, Alexei, Robinson, John H., Isaacs, John D., Hilkens, Catharien M. U.
Publicado 2009

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

por Lord, Phillip, Spiering, Rachel, Aguillon, Juan C., Anderson, Amy E., Appel, Silke, Benitez-Ribas, Daniel, ten Brinke, Anja, Broere, Femke, Cools, Nathalie, Cuturi, Maria Cristina, Diboll, Julie, Geissler, Edward K., Giannoukakis, Nick, Gregori, Silvia, van Ham, S. Marieke, Lattimer, Staci, Marshall, Lindsay, Harry, Rachel A., Hutchinson, James A., Isaacs, John D., Joosten, Irma, van Kooten, Cees, Lopez Diaz de Cerio, Ascension, Nikolic, Tatjana, Oral, Haluk Barbaros, Sofronic-Milosavljevic, Ljiljana, Ritter, Thomas, Riquelme, Paloma, Thomson, Angus W., Trucco, Massimo, Vives-Pi, Marta, Martinez-Caceres, Eva M., Hilkens, Catharien M.U.
Publicado 2016